F Dx Advisors, Inc. Eli Lilly & CO Transaction History

F Dx Advisors, Inc.

$367 Million
Q3 2024

A detailed history of F Dx Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, F Dx Advisors, Inc. holds 502 shares of LLY stock, worth $399,426. This represents 0.12% of its overall portfolio holdings.

Number of Shares

502

Previous 520 3.46%

Holding current value

$399,426

Previous $471,000 5.52%

% of portfolio

0.12%

Previous 0.13%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$772.14 - $960.02 $13,898 - $17,280	-18 Reduced 3.46%	502 $445,000
Q2 2024 Aug 02, 2024	SELL	$724.87 - $909.04 $6.28 Million - $7.88 Million	-8,664 Reduced 94.34%	520 $471,000
Q1 2024 May 03, 2024	SELL	$592.2 - $792.28 $862,243 - $1.15 Million	-1,456 Reduced 13.68%	9,184 $7.15 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $1.64 Million - $1.94 Million	-3,129 Reduced 22.72%	10,640 $6.2 Million
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $3.95 Million - $5.45 Million	-9,093 Reduced 39.77%	13,769 $7.4 Million
Q2 2023 Jul 17, 2023	SELL	$350.74 - $468.98 $1.62 Million - $2.16 Million	-4,614 Reduced 16.79%	22,862 $10.7 Million
Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $78,136 - $91,044	243 Added 0.89%	27,476 $10.1 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $1.25 Million - $1.42 Million	-4,216 Reduced 13.41%	27,233 $8.81 Million
Q2 2022 Aug 03, 2022	SELL	$278.73 - $327.27 $952,699 - $1.12 Million	-3,418 Reduced 9.8%	31,449 $10.2 Million
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $2.34 Million - $2.9 Million	-9,955 Reduced 22.21%	34,867 $9.99 Million
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $349,192 - $433,349	1,553 Added 3.59%	44,822 $12.4 Million
Q3 2021 Oct 08, 2021	BUY	$221.6 - $272.71 $329,297 - $405,247	1,486 Added 3.56%	43,269 $10 Million
Q2 2021 Aug 05, 2021	BUY	$180.55 - $233.54 $857,431 - $1.11 Million	4,749 Added 12.82%	41,783 $9.59 Million
Q1 2021 Apr 14, 2021	BUY	$164.32 - $212.72 $4.95 Million - $6.41 Million	30,115 Added 435.25%	37,034 $6.92 Million
Q1 2021 Apr 13, 2021	SELL	$164.32 - $212.72 $5.74 Million - $7.43 Million	-34,949 Reduced 83.47%	6,919 $1.29 Million
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $160,204 - $211,989	-1,228 Reduced 2.85%	41,868 $7.07 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $1.69 Million - $1.96 Million	11,585 Added 36.76%	43,096 $6.38 Million
Q2 2020 Jul 22, 2020	BUY	$136.42 - $164.18 $622,211 - $748,824	4,561 Added 16.92%	31,511 $5.17 Million
Q1 2020 May 22, 2020	BUY	$119.05 - $147.35 $1.15 Million - $1.42 Million	9,662 Added 55.89%	26,950 $3.74 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $350,483 - $433,798	-2,944 Reduced 14.55%	17,288 $459,000
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $792,918 - $982,100	7,416 Added 57.87%	20,232 $2.66 Million
Q3 2019 Nov 07, 2019	SELL	$106.79 - $116.16 $204,075 - $221,981	-1,911 Reduced 12.98%	12,816 $1.43 Million
Q2 2019 Jul 19, 2019	BUY	$110.79 - $129.32 $86,416 - $100,869	780 Added 5.59%	14,727 $1.63 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $129,230 - $152,114	1,161 Added 9.08%	13,947 $1.81 Million
Q4 2018 Apr 29, 2019	SELL	$105.9 - $118.64 $711,436 - $797,023	-6,718 Reduced 34.44%	12,786 $1.48 Million
Q4 2018 Feb 07, 2019	BUY	$105.9 - $118.64 $673,100 - $754,075	6,356 Added 48.34%	19,504 $2.26 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $178,502 - $223,097	-2,079 Reduced 13.65%	13,148 $1.41 Million
Q2 2018 Aug 08, 2018	SELL	$75.7 - $86.88 $2.09 Million - $2.4 Million	-27,579 Reduced 64.43%	15,227 $1.3 Million
Q1 2018 May 02, 2018	SELL	$74.21 - $87.6 $1.94 Million - $2.29 Million	-26,122 Reduced 37.9%	42,806 $3.31 Million
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $1.69 Million - $1.81 Million	-20,624 Reduced 23.03%	68,928 $5.82 Million
Q3 2017 Nov 03, 2017	BUY	$77.07 - $85.54 $8,554 - $9,494	111 Added 0.12%	89,552 $7.66 Million
Q2 2017 Aug 11, 2017	BUY	N/A	89,441	89,441 $7.36 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account